MyFinsight
Home
Blog
About
United States Segment
$1,003,500K
(12.79%↑ Y/Y)
Europe Segment
$439,600K
(16.23%↑ Y/Y)
Rest Of World Segment
$201,500K
(19.23%↑ Y/Y)
Japan Segment
$96,400K
(1.15%↑ Y/Y)
Net sales
$1,741,000K
(13.63%↑ Y/Y)
Gross profit
$1,348,600K
(13.54%↑ Y/Y)
Other operating
income
$11,000K
(-48.36%↓ Y/Y)
Cost of sales
$392,400K
(13.94%↑ Y/Y)
Operating income, net
$513,200K
(24.81%↑ Y/Y)
Interest income, net
$30,000K
(-19.79%↓ Y/Y)
Selling, general, and
administrative expenses
$561,200K
(11.79%↑ Y/Y)
Research and development
expenses
$278,900K
(0.98%↑ Y/Y)
Other non-operating
(income) expense, net...
$16,600K
(1376.92%↑ Y/Y)
Certain litigation
expenses
$6,300K
(-59.35%↓ Y/Y)
Income from continuing
operations before...
$519,800K
(29.89%↑ Y/Y)
Loss on impairment
(note 6)
$40,000K
Net income from
continuing operations
$241,400K
(-28.13%↓ Y/Y)
Provision for income taxes
$278,400K
(332.97%↑ Y/Y)
Net income
$241,400K
(-27.18%↓ Y/Y)
Less net loss
attributable to...
-$500K
(70.59%↑ Y/Y)
Net income
attributable to edwards...
$241,900K
(-27.40%↓ Y/Y)
Back
Back
Income Statement
logo (34)-svg
Edwards Lifesciences Corp (EW)
logo (34)-svg
source: myfinsight.com
Edwards Lifesciences Corp (EW)